BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37850144)

  • 1.
    Niu Z; Luo Z; Sun P; Ning L; Jin X; Chen G; Guo C; Zhi L; Chang W; Zhu W
    Biodes Res; 2022; 2022():9823578. PubMed ID: 37850144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of Synthetic Nanobody Library in Mammalian Cells by dsDNA-Based Strategies*.
    Zhao Y; Wang Y; Su W; Li S
    Chembiochem; 2021 Oct; 22(20):2957-2965. PubMed ID: 34411391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Nanobody Scaffold Optimized for Bacterial Expression and Suitable for the Construction of Ribosome Display Libraries.
    Ferrari D; Garrapa V; Locatelli M; Bolchi A
    Mol Biotechnol; 2020 Jan; 62(1):43-55. PubMed ID: 31720928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDR grafting and site-directed mutagenesis approach for the generation and affinity maturation of Anti-CD20 nanobody.
    Heidari MM; Shirazi EA; Cheraghi SF; Shahshahani R; Rahnama T; Khatami M
    Mol Biol Rep; 2024 Jun; 51(1):751. PubMed ID: 38874667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Domain swapping of complementarity-determining region in nanobodies produced by Pichia pastoris.
    Miura N; Miyamoto K; Ohtani Y; Yaginuma K; Aburaya S; Kitagawa Y; Aoki W; Ueda M
    AMB Express; 2019 Jul; 9(1):107. PubMed ID: 31309388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive charge in the complementarity-determining regions of synthetic nanobody prevents aggregation.
    Zhong Z; Yang Y; Chen X; Han Z; Zhou J; Li B; He X
    Biochem Biophys Res Commun; 2021 Oct; 572():1-6. PubMed ID: 34332323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yeast surface display platform for rapid discovery of conformationally selective nanobodies.
    McMahon C; Baier AS; Pascolutti R; Wegrecki M; Zheng S; Ong JX; Erlandson SC; Hilger D; Rasmussen SGF; Ring AM; Manglik A; Kruse AC
    Nat Struct Mol Biol; 2018 Mar; 25(3):289-296. PubMed ID: 29434346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Two-Step Approach for the Design and Generation of Nanobodies.
    Wagner HJ; Wehrle S; Weiss E; Cavallari M; Weber W
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ModiBodies: A computational method for modifying nanobodies in nanobody-antigen complexes to improve binding affinity and specificity.
    Hacisuleyman A; Erman B
    J Biol Phys; 2020 Jun; 46(2):189-208. PubMed ID: 32418062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and Production of a Novel Anti-PD-1 Nanobody by CDR Grafting and Site-Directed Mutagenesis Approach.
    Mirzaei M; Mirhoseini S; Heidari MM; Khatami M
    Mol Biotechnol; 2024 May; ():. PubMed ID: 38736021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of anti-aflatoxin B1 nanobodies from a novel mutagenesis-derived synthetic library for traditional Chinese medicine and foods safety testing.
    Lee YC; Lai GH; Lin TY; Tseng TS; Tsai TH; Chen WC; Lee CC; Tsai KC
    J Biol Eng; 2023 Apr; 17(1):30. PubMed ID: 37095503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct Blockade of the Norovirus Histo-Blood Group Antigen Binding Pocket by Nanobodies.
    Kher G; Sabin C; Lun JH; Devant JM; Ruoff K; Koromyslova AD; von Itzstein M; Pancera M; Hansman GS
    J Virol; 2023 Apr; 97(4):e0183322. PubMed ID: 36971561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation and Screening of Antigen-Specific Nanobodies from Mammalian Cells Expressing the BCR Repertoire Library Using Droplet-Based Microfluidics.
    Lyu M; Shi X; Liu X; Liu Y; Zhu X; Liao L; Zhao H; Sun N; Wang S; Chen L; Fan L; Xu Q; Zhu Q; Gao K; Chen H; Zhu Y; Li Z; Guo W; Zheng Y; Gu Y; Liu L; Wang M; Liu Y
    Anal Chem; 2022 Jun; 94(22):7970-7980. PubMed ID: 35604850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studying the characteristics of nanobody CDR regions based on sequence analysis in combination with 3D structures.
    Truong TTT; Huynh VQ; Vo NT; Nguyen HD
    J Genet Eng Biotechnol; 2022 Nov; 20(1):157. PubMed ID: 36417012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural Insights into the Design of Synthetic Nanobody Libraries.
    Valdés-Tresanco MS; Molina-Zapata A; Pose AG; Moreno E
    Molecules; 2022 Mar; 27(7):. PubMed ID: 35408597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Humanizing Mutations on the Stability of the Llama Single-Domain Variable Region.
    Soler MA; Medagli B; Wang J; Oloketuyi S; Bajc G; Huang H; Fortuna S; de Marco A
    Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33530572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facile isolation of high-affinity nanobodies from synthetic libraries using CDR-swapping mutagenesis.
    Zupancic JM; Desai AA; Tessier PM
    STAR Protoc; 2022 Mar; 3(1):101101. PubMed ID: 35098159
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Zhu X; An K; Yan J; Xu P; Bai C
    Front Biosci (Landmark Ed); 2023 Apr; 28(4):67. PubMed ID: 37114534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of a scFv Library with Synthetic, Non-combinatorial CDR Diversity.
    Bai X; Shim H
    Methods Mol Biol; 2017; 1575():15-29. PubMed ID: 28255872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in the selection and identification of antigen-specific nanobodies.
    Liu W; Song H; Chen Q; Yu J; Xian M; Nian R; Feng D
    Mol Immunol; 2018 Apr; 96():37-47. PubMed ID: 29477934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.